Bellicum To Present At The Bank of America Merrill Lynch 2016 Health Care Conference

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced that Tom Farrell, President and CEO, is scheduled to present at the Bank of America Merrill Lynch 2016 Health Care Conference. The presentation will take place on Thursday, May 12 at 10:40am PDT (1:40pm EDT) in Las Vegas, NV.